Maternal adaptation in pregnant hypertensive rats: Improvement of vascular and inflammatory variables and oxidative damage in the Kidney

American Journal of Hypertension

Volumn 22, Issue 7, 2009, Pages 777-783

  Iacono, Anna ^a   Bianco, Giuseppe ^b   Mattace Raso, Giuseppina ^a   Esposito, Emanuela ^c   D'Emmanuele Di Villa Bianca, Roberta ^a   Sorrentino, Raffaella ^a   Cuzzocrea, Salvatore ^c,d   Calignano, Antonio ^a   Autore, Giuseppina ^b   Meli, Rosaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HEART RATE; INFLAMMATION; KIDNEY INJURY; LIPID PEROXIDATION; MACROPHAGE; MATERNAL HYPERTENSION; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION; WESTERN BLOTTING;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD PRESSURE; CHEMOKINE CCL2; CYCLOOXYGENASE 2; FEMALE; HEART RATE; HYPERTENSION; I-KAPPA B PROTEINS; KIDNEY; LIPID PEROXIDATION; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE TYPE II; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; TRANSCRIPTION FACTOR RELA; TYROSINE;

EID: 67649383320     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.68     Document Type: Article

References (40)

1. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963; 27:282-293.
2. Aoi W, Gable D, Cleary RE, Young PC, Weinberger MH. The antihypertensive effect of pregnancy in spontaneously hypertensive rats. Proc Soc Exp Biol Med 1976; 153:13-15.
3. Lindheimer MD, Katz AI, Koeppen BM, Ordóñez NG, Oparil S. Kidney function and sodium handling in the pregnant spontaneously hypertensive rat. Hypertension 1983; 5:498-506.
4. Zamorano B, Terragno A, McGiff JC, Terragno NA. A prostaglandin mechanism may contribute to the regulation of blood pressure in spontaneously hypertensive rats during pregnancy. Adv Prostaglandin Thromboxane Res 1980; 7:807-810.
5. Ahokas RA, Sibai BM. The relationship between experimentally determined litter size and maternal blood pressure in spontaneously hypertensive rats. Am J Obstet Gynecol 1990; 162:841-847.
6. Raso GM, Bianco G, Iacono A, Esposito E, Autore G, Ferrante MC, Calignano A, Meli R. Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation. J Endocrinol 2007; 194:611-619.
7. Arendshorst WJ, Brännström K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999; 10(Suppl 11):S149-S161.
8. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 1996; 76:425-536.
9. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 1999; 10(Suppl 12):S258-S265.
10. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205-251.
11. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, Abe M, Takeuchi K, Abe K, Ito S. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997; 100:2816-2823.
12. Zalba G, Beaumont FJ, San José G, Fortuño A, Fortuño MA, Etayo JC, Díez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-1061.
13. Zhan CD, Sindhu RK, Vaziri ND. Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int 2004; 65:219-227.
14. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41:341-346.
15. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann NY Acad Sci 1988; 524:103-121.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
17. Brenner CA, Tam AW, Nelson PA, Engleman EG, Suzuki N, Fry KE, Larrick JW. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. BioTechniques 1989; 7:1096-1103.
18. Racasan S, Braam B, Koomans HA, Joles JA. Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon. Am J Physiol Renal Physiol 2005; 288:F626-F636.
19. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377:748-750.
20. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996; 27: 760-765.
21. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997; 30:1238-1246.
22. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995; 377:744-747.
23. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999; 104:925-935.
24. Yang Y, Macdonald GJ, Duggan KA. Differential regulation of uterine and glomerular angiotensin II receptors in normal and hypertensive pregnancy in the rat. Clin Exp Pharmacol Physiol 1994; 21:253-256.
25. Beauséjour A, Auger K, St-Louis J, Brochu M. High-sodium intake prevents pregnancy-induced decrease of blood pressure in the rat. Am J Physiol Heart Circ Physiol 2003; 285:H375-H383.
26. Joyner J, Neves LA, Granger JP, Alexander BT, Merrill DC, Chappell MC, Ferrario CM, Davis WP, Brosnihan KB. Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 2007; 293:R169-R177.
27. Poisner AM. The human placental renin-angiotensin system. Front Neuroendocrinol 1998; 19:232-252.
28. Mattace Raso G, Bianco G, Esposito E, Iacono A, Meli R, Autore G. Evaluation of placental protein modifications in normotensive and spontaneously hypertensive rats. Placenta 2008; 29:429-435.
29. Cheng ZJ, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit 2005; 11:RA194-RA205.
30. Sanz-Rosa D, Oubiña MP, Cediel E, de Las Heras N, Vegazo O, Jiménez J, Lahera V, Cachofeiro V. Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. Am J Physiol Heart Circ Physiol 2005; 288:H111-H115.
31. Sironi L, Gelosa P, Guerrini U, Banfi C, Crippa V, Brioschi M, Gianazza E, Nobili E, Gianella A, de Gasparo M, Tremoli E. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. J Pharmacol Exp Ther 2004; 311:989-995.
32. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-260.
33. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000; 12:85-98.
34. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 2005; 315:51-57.
35. Sun L, Gao YH, Tian DK, Zheng JP, Zhu CY, Ke Y, Bian K. Inflammation of different tissues in spontaneously hypertensive rats. Sheng Li Xue Bao 2006; 58:318-323.
36. Ulker S, McMaster D, McKeown PP, Bayraktutan U. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res 2003; 59:488-500.
37. Kaiserová H, Simunek T, Sterba M, den Hartog GJ, Schröterová L, Popelová O, Gersl V, Kvasnicková E, Bast A. New iron chelators in anthracycline-induced cardiotoxicity. Cardiovasc Toxicol 2007; 7:145-150.
38. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, Johnson RJ, Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002; 282:F191-F201.
39. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab 2007; 18:365-370.
40. Mohaupt M. Molecular aspects of preeclampsia. Mol Aspects Med 2007; 28: 169-191.